Syngene Appoints Talented, New International Sales Manager
News May 30, 2015
Syngene has announced the appointment of Matthew Dunne, as its new International Sales Manager. The firm has appointed Matthew at this time to capitalize on the increasing demand for quality assured gel imaging systems, especially in the Middle East and Asia Pacific regions.
Matthew comes to Syngene with a wealth of experience, having been active in sales management and sales for life science product suppliers, including a major international gel documentation company for over 16 years. His imaging expertise is supported by a masters degree in parasitology and medical entomology from the Liverpool School of Tropical Medicine and a degree in biology from the University of Liverpool. Additionally, Matthew is passionate about producing the best digital imaging both professionally and personally, as photography is also his hobby.
Commenting on his appointment, Matthew Dunne stated: “I’m excited to be joining Syngene as it is a company I have wanted to have the opportunity to work with for some years. I’m looking forward to being part of the Syngene team and to building close relationships with the network of international distributors in Africa, Asia Pacific and the Middle East and to being guided by them to provide the support they need to skilfully promote and support Syngene’s range of excellent products.”
Matthew Dunne’s appointment is part of Syngene’s parent company, Synoptics’s wider commercial strategy to actively market Syngene and Synbiosis ranges globally. This approach has also recently seen Martin Biggs, who has been with Syngene since 2012 being promoted to Sales and Marketing Director for Synoptics and also the recruitment of Guy Fiddian as a new Internal Sales Coordinator at Synoptics. Both Martin and Guy will also provide client driven support of Syngene and Synbiosis systems for scientists, sales professionals and distributors.
Martin Biggs, Synoptics Sales and Marketing Director, concluded: “We are delighted to recruit such a talented International Sales Manager with Matthew Dunne and know that he will have the drive and passion to strengthen the relationships with our distributors to ensure a very successful future for Syngene.”
How To Build A Better Railway - In (Almost) Every Cell In Your BodyNews
New research from the University of Warwick shows how a microscopic ‘railway’ system in our cells can optimise its structure to better suit bodies’ needs.READ MORE
‘Digistain’ Technology Offers Revolution in Detailed Cancer DiagnosisNews
New cutting edge technology can be used to grade cancer tumours, eradicating human subjectivity and ensuring patients get the right treatment.READ MORE
Understanding 'Disease Mechanisms' of ALSNews
Researchers are making strides in understanding the disease mechanism of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. They recently found that ubiquitin eliminates droplets of Ubiquilin-2 (UBQLN2) in solution. The discovery is noteworthy because UBQLN2 is a protein-encoding gene, mutations to which cause ALS and various types of dementia.READ MORE
Comments | 0 ADD COMMENT
World Congress on Clinical And Medical Microbiology
Sep 10 - Sep 11, 2018